CN Stock MarketDetailed Quotes

688289 Sansure Biotech Inc.

Watchlist

22.45
-1.12-4.75%

Market Closed Nov 22 15:00 CST

13.07BMarket Cap50.45P/E (TTM)

Sansure Biotech Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sansure Biotech Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 2.009B	--
--	2024/FY	-- / 1.496B	--
--	2023/FY	1.006B / --	--
--	2021/FY	4.515B / 4.321B	--
--	2020/FY	4.767B / 5.080B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 2.009B--

--2024/FY-- / 1.496B--

--2023/FY1.006B / ----

--2021/FY4.515B / 4.321B--

--2020/FY4.767B / 5.080B--

Unlock Free Earnings Estimates

Open Account

Sansure Biotech Inc. Earnings Reports

Shengxiang Biology: Shengxiang Biotechnology Co., Ltd. Report for the Third Quarter of 2024

Oct 23 12:00 ET

Shengxiang Biotechnology Co., Ltd. Report for the Third Quarter of 2024

Oct 23 12:00 ET

Full text of Sansure Biotech Inc.'s 2024 interim report

Aug 18 12:00 ET

Summary of Sansure Biotech Inc.'s 2024 half-yearly report.

Aug 18 12:00 ET

Analyst Rating

Updated: Nov 22, 2024

Strong Buy

Strong Buy
83.33%
Buy
16.67%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall